PMID- 17119916 OWN - NLM STAT- MEDLINE DCOM- 20070926 LR - 20181113 IS - 0012-186X (Print) IS - 0012-186X (Linking) VI - 50 IP - 2 DP - 2007 Feb TI - Exercise under hyperinsulinaemic conditions increases whole-body glucose disposal without affecting muscle glycogen utilisation in type 1 diabetes. PG - 414-21 AB - AIMS/HYPOTHESIS: We examined whole-body and muscle metabolism in patients with type 1 diabetes during moderate exercise at differing circulating insulin concentrations. METHODS: Eight men (mean +/- SEM age 36.4 +/- 1.5 years; diabetes duration 11.3 +/- 1.4 years; BMI 24.6 +/- 0.7 kg/m(2); HbA(1c) 7.9 +/- 0.2% and VO(2) peak 44.5 +/- 1.2 ml kg(-1) min(-1)) with type 1 diabetes were studied on two occasions at rest (2 h) and during 45 min of cycling at 60% maximum VO(2) with insulin infused at the rate of either 15 (LO study) or 50 (HI) mU m(-2) min(-1) and blood glucose clamped at 8 mmol/l. Indirect calorimetry, insulin-glucose clamps and thigh muscle biopsies were employed to measure whole-body energy and muscle metabolism. RESULTS: Fat oxidation contributed 15 and 23% to total energy expenditure during exercise in the HI and LO studies, respectively. The respective carbohydrate (CHO) oxidation rates were 31.7 +/- 2.7 and 27.8 +/- 1.9 mg kg(-1) min(-1) (p < 0.05). Exogenous glucose utilisation rate during exercise was substantially greater (p < 0.001) in the HI study (18.4 +/- 2.1 mg kg(-1) min(-1)) than in the LO study (6.9 +/- 1.2 mg kg(-1) min(-1)). Muscle glycogen content fell by approximately 40% during exercise in both trials. Muscle glycogen utilisation, muscle intermediary metabolism, and phosphorylation of protein kinase B/Akt, glycogen synthase kinase 3alpha/beta and extracellular signal-regulated protein kinase 1 and 2 proteins were no different between interventions. CONCLUSIONS/INTERPRETATION: In patients with type 1 diabetes, exercise under peak therapeutic insulin concentrations increases exogenous glucose utilisation but does not spare muscle glycogen utilisation. A disproportionate increase in exogenous glucose utilisation relative to the increase in CHO oxidation suggests an increase in glucose flux through non-oxidative pathways. FAU - Chokkalingam, K AU - Chokkalingam K AD - Department of Diabetes and Endocrinology, Queen's Medical Centre, Nottingham, UK. FAU - Tsintzas, K AU - Tsintzas K FAU - Norton, L AU - Norton L FAU - Jewell, K AU - Jewell K FAU - Macdonald, I A AU - Macdonald IA FAU - Mansell, P I AU - Mansell PI LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20061121 PL - Germany TA - Diabetologia JT - Diabetologia JID - 0006777 RN - 0 (Blood Glucose) RN - 0 (Insulin) RN - 9005-79-2 (Glycogen) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Adult MH - Blood Glucose/*metabolism MH - Diabetes Mellitus, Type 1/blood/*physiopathology MH - Energy Metabolism MH - Exercise/*physiology MH - Glucose/*metabolism MH - Glycogen/metabolism MH - Humans MH - Hyperinsulinism/*blood MH - Insulin/blood MH - Male MH - Middle Aged MH - Muscle, Skeletal/*physiopathology MH - Oxygen Consumption EDAT- 2006/11/23 09:00 MHDA- 2007/09/27 09:00 CRDT- 2006/11/23 09:00 PHST- 2006/07/28 00:00 [received] PHST- 2006/09/19 00:00 [accepted] PHST- 2006/11/23 09:00 [pubmed] PHST- 2007/09/27 09:00 [medline] PHST- 2006/11/23 09:00 [entrez] AID - 10.1007/s00125-006-0520-0 [doi] PST - ppublish SO - Diabetologia. 2007 Feb;50(2):414-21. doi: 10.1007/s00125-006-0520-0. Epub 2006 Nov 21.